查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1198701

泌尿外科设备市场 - COVID-19 的增长、趋势、影响和预测 (2023-2028)

Urology Devices Market - Growth, Trends, and Forecasts (2023 - 2028)
出版日期: | 出版商: Mordor Intelligence | 英文 118 Pages | 商品交期: 2-3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

预计在预测期内（2022-2027 年），全球泌尿外科设备市场将以 6.35% 的增长率增长。

COVID-19 的全球传播使许多医疗保健机构挤满了危重病人和透析机、内窥镜和碎石机等医疗设备。 COVID-19 会导致个人出现急性呼吸窘迫和急性肾损伤。 当患者的身体无法清除体内多余的废物和液体时，就会发生多器官衰竭和肾衰竭。 由于透析机用于治疗患者，泌尿外科设备市场将对 COVID-19 产生有益影响。 然而，在大流行期间，泌尿外科实践有所下降。 因此，COVID-19 将对所研究的市场产生不同的影响。

推动市场增长的主要因素是泌尿外科设备的高发率、老年人口的增加和技术进步。

根据美国泌尿外科协会基金会 (AUAF) 的数据，良性前列腺增生症 (BPH)、尿失禁 (UI)、尿路感染 (UTI)、肾结石和输尿管结石是最常见的泌尿外科器械之一。 根据美国国家医学研究所的数据，2020 年 7 月，尿路感染影响全球约 1.5 亿人。 大约 11% 的女性每年去看医生一次以治疗尿路感染。 尿路感染 (UTI) 是影响所有年龄段人群的最常见的微生物疾病之一。 全世界每年约有 1.5 亿人患有尿路感染。 糖尿病患者发生尿路感染的风险很高。 排尿困难和器官损伤等并发症与尿路结石有关，并且随着世界糖尿病人口的增加而增加。

此外，根据 2020 年 8 月发表在《国际分子医学杂誌》上的一篇论文，肾结石，也称为肾结石或尿路结石，是最古老的医学疾病之一。 ...显然 ... 据估计，有 11% 的人会在一生中的某个时候患上肾结石，而且全世界肾结石的患病率和发病率都在上升。 然而，尿石症的总体患病率为11.2%，48.8%的一级亲属患有该病。 此外，男性患尿路结石的可能性是女性的 1.8 倍。

因此，由于与泌尿外科设备相关的高发病率和健康并发症，对管理它们的医疗干预的需求不断增加，这反过来又推动了泌尿外科设备市场。它是

泌尿外科设备市场趋势

肾臟疾病领域预计将占据最高市场份额

肾臟有多种疾病，如肾囊肿、囊性肾病、慢性肾病、溶血性尿毒症综合征、软玉狼疮等。 由于许多肾臟疾病会导致肾功能衰竭，因此需要及早诊断以便及时治疗。

根据 Onecia Benjamin 和 Sarah L. Lappin 于 2021 年 9 月发表的一篇论文，终末期肾病 (ESRD) 每年影响美国超过 500,000 人。 CKD 的患病率随着年龄的增长而增加，该病在 60 岁以上的人群中进展最快。 18 至 44 岁人群的频率为 6.0%，65 岁及以上人群的频率为 38.1%。

美国国家糖尿病、消化和肾臟疾病研究所 (NIDDK) 2020，ESKD，也称为终末期肾病 (ESRD)，影响美国近 786,000 人，其中 71% 接受透析，29% 接受肾移植将需要。 据说 ESKD 会影响受影响的男性中的三分之一和女性中的二分之一。 然而，大多数人在早期阶段仍未得到诊断，最终在世界各地死亡。

因此，意识的提高、政府通过报销提供的支持以及产品创新以开发低成本和有效的治疗方法是预计在预测期内推动市场发展的因素。我在这里。

北美主导市场，预计在预测期内会出现同样的趋势

目前，北美在泌尿外科市场拥有压倒性的实力，这种势头有望在未来持续下去。 良性前列腺增生症 (BPH) 是泌尿外科市场中最未开发的部分之一。 几家总部位于美国的公司正致力于通过合作或收购来升级该领域的设备。

该地区在与尿路结石诊断技术相关的技术创新方面取得了重大进展。 在 Pranita D. Tamma 于 2020 年 11 月发表于美国传染病学会的一篇论文中，一名妇女在尿路常规检查中被诊断出患有大肠桿菌，这种大肠桿菌对最后一道防线抗生素粘菌素具有耐药性结石。据观察，他被感染了。 粘菌素耐药细菌的发现被认为是一个主要问题。 此外，CDC 还与其他组织合作制定了在美国预防与医疗保健相关的感染（例如与导管相关的尿石）的指南。 尿石症造成重大的社会和个人负担，导緻美国每年有大量就医。 这种情况增加了泌尿外科设备的销量并带动了市场。

因此，技术进步、医院泌尿外科病例比例高以及资金增加预计将成为预测期内泌尿外科设备市场增长的主要因素。

泌尿外科器械市场竞争者分析

泌尿外科设备市场竞争激烈，由几家大型企业组成。 随着技术进步和产品创新不断，中小企业有望通过以更低的价格推出新设备来提高其市场占有率。 百特、波士顿科学、C.R. Bardo、美敦力和西门子等公司占据了相当大的市场份额。

其他好处

  • Excel 格式的市场预测 (ME) 表
  • 三个月的分析师支持

内容

第一章介绍

  • 研究假设和市场定义
  • 调查范围

第二章研究方法论

第 3 章执行摘要

第四章市场动态

  • 市场概览
  • 市场驱动力
    • 泌尿外科设备的高发率
    • 老年人口增加
    • 技术进步
  • 市场製约因素
    • 严格的医疗器械验证监管政策
    • 泌尿外科设备成本高
  • 波特的五力分析
    • 新进入者的威胁
    • 买方/消费者议价能力
    • 供应商的议价能力
    • 替代品的威胁
    • 竞争公司之间的敌对关係

第 5 章市场细分（基于价值的市场规模：百万美元）

  • 按产品分类
    • 医疗设备
      • 透析器
      • 内窥镜和内窥镜系统
      • 激光和微积分粉碎机
      • 其他设备
    • 按耗材和配件
      • 透析相关耗材
      • 导丝和导管
      • 支架
      • 活检装置
      • 其他消耗品和配件
  • 按疾病分类
    • 肾臟疾病
    • 泌尿系统癌症、良性前列腺增生
    • 盆腔器官脱垂
    • 其他疾病
  • 最终用户
    • 医院和诊所
    • 透析中心
    • 其他最终用户
  • 按地区
    • 北美
      • 美国
      • 加拿大
      • 墨西哥
    • 欧洲
      • 德国
      • 英国
      • 法国
      • 意大利
      • 西班牙
      • 其他欧洲地区
    • 亚太地区
      • 中国
      • 日本
      • 印度
      • 澳大利亚
      • 韩国
      • 其他亚太地区
    • 中东
      • 海湾合作委员会
      • 南非
      • 其他中东地区
    • 南美洲
      • 巴西
      • 阿根廷
      • 其他南美洲

第六章竞争格局

  • 公司简介
    • Baxter International Inc.
    • Boston Scientific Corporation
    • Becton, Dickinson and Company
    • Cook Medical Incorporated
    • Stryker Corporation
    • Fresenius Medical Care AG & Co. KGaA
    • Intuitive Surgical Inc.
    • Karl Storz SE & Co. KG
    • Medtronic PLC
    • Olympus Corporation

第7章 市场机会今后动向

简介目录
Product Code: 60485

The global urology devices market is growing at a rate of 6.35% during the forecast period (2022-2027).

The global spread of COVID-19 has flooded many healthcare institutions with severely ill patients and medical equipment such as dialysis machines, endoscopes, and lithotripsy machines. COVID-19 causes acute respiratory distress and acute renal damage in individuals. Multi-organ failure and renal failure can occur when the patient's body cannot remove excess waste and fluids from the body. As a result of the use of dialysis equipment in the treatment of patients, the urology device market has a beneficial impact on COVID-19. However, urology practices have decreased during the pandemic. Thus, COVID-19 has a mixed impact on the market studied.

The key factors propelling the market growth include a high incidence of urologic conditions, a rising senior population, and technological advancements.

According to the American Urological Association Foundation (AUAF), benign prostatic hyperplasia (BPH), urinary incontinence (UI), urinary tract infections (UTIs), and kidney and ureteral stones are among the most common urological diseases. The United States According to the National Institute of Medicine July 2020, urinary tract infection affects approximately 150 million people globally. In addition, about 11% of women visit one physician yearly for urinary tract infection treatment. Urinary tract infections (UTIs) are among the most common microbial diseases affecting people of all ages. Globally, UTIs affect around 150 million people every year. Diabetic patients have a higher risk of developing UTIs. With a global increase in the diabetic population, complications like dysuria and organ damage are associated with UTIs, which are also rising.

Additionally, according to the article published in the International Journal of Molecular medicine in August 2020, Kidney stone disease, also known as nephrolithiasis or urolithiasis, is one of medicine's oldest diseases. It is estimated that 11% of people will develop kidney stones at some point in their lives, and the prevalence and incidence of kidney stones are increasing worldwide. However, the overall prevalence of urolithiasis was 11.2 %, with 48.8 % having a first-degree relative with the disease. Males were 1.8 times more likely than females to have urolithiasis.

Hence, with the high incidence rates and health complications associated with urological diseases, there is an increasing demand for healthcare interventions to manage them, which, in turn, is propelling the market of urology devices market.

Urology Devices Market Trends

Kidney Disease Segment Expected to Hold the Highest Market Share

The various kidney diseases include renal cyst, cystic kidney diseases, chronic kidney disease, hemolytic-uremic syndrome, and lupus nephrite, among others. Most kidney diseases lead to kidney failure, which requires early diagnosis for prompt treatment.

According to the article published in the National Institutes of Health in September 2021 by Onecia Benjamin and Sarah L. Lappin., End-stage renal disease (ESRD) affects more than 500,000 persons in the United States annually. The prevalence of CKD rises with age, with persons aged 60 and up experiencing the fastest development. The frequency is 6.0 % among those aged 18 to 44 and 38.1% among those aged 65 and up.

National Institute on Diabetes and Digestive and Kidney Diseases (NIDDK) in 2020, ESKD, also known as an end-stage renal disease (ESRD), affects almost 786,000 people in the United States with 71% requiring dialysis and 29% requiring a kidney transplant. ESKD affects three men and every two women who develop it. However, most of the population remains undiagnosed in the early stages, eventually leading to death worldwide.

Therefore, an increase in awareness, along with support from the government through reimbursement and innovation in products to develop a low-cost and effective treatment, are some elements expected to drive the market over the forecast period.

North America is Dominating the Market and is Expected to do the Same During the Forecast Period

North America currently dominates the market for urology devices, and it is expected to continue its stronghold for a few more years. Benign prostatic hyperplasia (BPH) is among the most untapped segments in the urology market. Several United States-based companies are working on upgrading their devices in this segment, either by collaboration or acquisition.

The region is experiencing a drastic increase in innovations related to diagnostic methodologies used for UTIs. According to the article published in Infectious Diseases Society of America in November 2020, by Pranita D. Tamma, during a routine checkup for a UTI, a woman was observed to be infected by E. coli that showed resistance to the last-resort antibiotic, Colistin. The discovery of Colistin-resistant bacteria was considered a major issue. In addition to that, the CDC, in collaboration with other organizations, developed guidelines for preventing catheter-associated UTIs and other healthcare-associated infections in the United States. UTIs are a substantial societal and personal burden, accounting for many medical visits in the United States each year. This condition drives the market by increasing sales of urology devices.

Thus, over the forecast period, technological advancements, a high percentage of urology cases in hospitals, and increasing funding are expected to be the major drivers for the growth of the urology devices market.

Urology Devices Market Competitor Analysis

The urology devices market is highly competitive and consists of several major players. With increasing technological advancements and product innovations, mid-size to smaller companies are expected to increase their market presence by introducing new devices at lesser prices. These companies, like Baxter, Boston Scientific, C. R. Bard, Medtronic, and Siemens, hold a substantial share in the market.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 High Incidence of Urologic Conditions
    • 4.2.2 Rising Geriatric Population
    • 4.2.3 Technological Advancements
  • 4.3 Market Restraints
    • 4.3.1 Stringent Regulatory Policies for Validation of Medical Devices
    • 4.3.2 High Cost of Urology Devices
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value - USD million)

  • 5.1 By Product
    • 5.1.1 Instruments
      • 5.1.1.1 Dialysis Devices
      • 5.1.1.2 Endoscopes and Endovision Systems
      • 5.1.1.3 Lasers and Lithotripsy Devices
      • 5.1.1.4 Other Instruments
    • 5.1.2 By Consumables and Accessories
      • 5.1.2.1 Dialysis Consumables
      • 5.1.2.2 Guidewires and Catheters
      • 5.1.2.3 Stents
      • 5.1.2.4 Biopsy Devices
      • 5.1.2.5 Other Consumables and Accessories
  • 5.2 By Disease
    • 5.2.1 Kidney Diseases
    • 5.2.2 Urological Cancer and BPH
    • 5.2.3 Pelvic Organ Prolapse
    • 5.2.4 Other Diseases
  • 5.3 By End User
    • 5.3.1 Hospitals and Clinics
    • 5.3.2 Dialysis Centers
    • 5.3.3 Other End Users
  • 5.4 Geography
    • 5.4.1 North America
      • 5.4.1.1 United States
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 Germany
      • 5.4.2.2 United Kingdom
      • 5.4.2.3 France
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South Korea
      • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle-East
      • 5.4.4.1 GCC
      • 5.4.4.2 South Africa
      • 5.4.4.3 Rest of Middle-East
    • 5.4.5 South America
      • 5.4.5.1 Brazil
      • 5.4.5.2 Argentina
      • 5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Baxter International Inc.
    • 6.1.2 Boston Scientific Corporation
    • 6.1.3 Becton, Dickinson and Company
    • 6.1.4 Cook Medical Incorporated
    • 6.1.5 Stryker Corporation
    • 6.1.6 Fresenius Medical Care AG & Co. KGaA
    • 6.1.7 Intuitive Surgical Inc.
    • 6.1.8 Karl Storz SE & Co. KG
    • 6.1.9 Medtronic PLC
    • 6.1.10 Olympus Corporation

7 MARKET OPPORTUNITIES AND FUTURE TRENDS